Faculty Collaboration Database

Christopher J. Schultz MD

Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology
Program: Clinical

Member of the Cancer Center
Member of the Mellowes Center for Genomic Sciences and Precision Medicine
Member of the Neuroscience Research Center

Send Message

Request Meeting

View Curriculum Vitae

Publications (149)

Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma. (Fleming JL, Pugh SL, Chang SM, McElroy JP, Becker AP, Aldape KD, Shih HA, Ashby LS, Hunter GK, Bahary JP, Schultz CJ, Kavanagh BD, Puduvalli VK, Robins HI, Werner-Wasik M, Mehta M, Chakravarti A) Int J Radiat Oncol Biol Phys 2025 Sep 01;123(1):84-92 PMID: 40164352 PMCID: PMC12857254 SCOPUS ID: 2-s2.0-105012631632 04/01/2025 2 Citations

Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic Associations. (Hall WA, Mathison AJ, DeVoe E, Tschannen M, Wendt-Andrae J, Straza M, Awan M, Puckett LL, Lawton CAF, Schultz C, Urrutia R, Kerns S, Torres-Roca JF, Li XA, Erickson B, Nevalainen MT, Zimmermann MT, Paulson E) Int J Radiat Oncol Biol Phys 2024 Oct 01;120(2):570-578 PMID: 38819340 SCOPUS ID: 2-s2.0-85194948255 05/31/2024 1 Citation

Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy. (Westerhoff JM, Daamen LA, Christodouleas JP, Blezer ELA, Choudhury A, Westley RL, Erickson BA, Fuller CD, Hafeez S, van der Heide UA, Intven MPW, Kirby AM, Lalondrelle S, Minsky BD, Mook S, Nowee ME, Marijnen CAM, Orrling KM, Sahgal A, Schultz CJ, Faivre-Finn C, Tersteeg RJHA, Tree AC, Tseng CL, Schytte T, Silk DM, Eggert D, Luzzara M, van der Voort van Zyp JRN, Verkooijen HM, Hall WA) JAMA Netw Open 2024 May 01;7(5):e2410819 PMID: 38691356 PMCID: PMC11063805 SCOPUS ID: 2-s2.0-85192045091 05/01/2024 16 Citations

Cystic Brain Metastasis Outcomes After Gamma Knife Radiation Therapy. (Amidon RF, Livingston K, Kleefisch CJ, Martens M, Straza M, Puckett L, Schultz CJ, Mueller WM, Connelly JM, Noid G, Morris K, Bovi JA) Adv Radiat Oncol 2024 Jan;9(1):101304 PMID: 38260234 PMCID: PMC10801666 SCOPUS ID: 2-s2.0-85167453267 01/23/2024 2 Citations

Cystic Brain Metastasis Outcomes After Gamma Knife Radiation Therapy (Amidon RF, Livingston K, Kleefisch CJ, Martens M, Straza M, Puckett L, Schultz CJ, Mueller WM, Connelly JM, Noid G, Morris K, Bovi JA) Advances in Radiation Oncology January 2024;9(1) SCOPUS ID: 2-s2.0-85167453267 01/01/2024 2 Citations

Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear Accelerator. (Schottstaedt AM, Paulson ES, Rubenstein JC, Chen X, Omari EA, Li XA, Schultz CJ, Puckett LL, Robinson CG, Alongi F, Gore EM, Hall WA) Phys Imaging Radiat Oncol 2023 Oct;28:100504 PMID: 38035207 PMCID: PMC10682663 SCOPUS ID: 2-s2.0-85176356378 11/30/2023 5 Citations

Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers. (Quashie EE, Li XA, Prior P, Awan M, Schultz C, Tai A) Phys Med Biol 2023 Dec 11;68(24) PMID: 37903437 SCOPUS ID: 2-s2.0-85180013067 10/31/2023 7 Citations

Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear Accelerator (Schottstaedt AM, Paulson ES, Rubenstein JC, Chen X, Omari EA, Li XA, Schultz CJ, Puckett LL, Robinson CG, Alongi F, Gore EM, Hall WA) Physics and Imaging in Radiation Oncology October 2023;28 SCOPUS ID: 2-s2.0-85176356378 10/01/2023 5 Citations

Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United States (Raldow AC, Siker ML, Bonner JA, Chen Y, Liu FF, Metz JM, Movsas B, Potters L, Schultz CJ, Wilson E, Wang X, Romero T, Steinberg ML, Jagsi R) Advances in Radiation Oncology 1 September 2023;8(5) SCOPUS ID: 2-s2.0-85153065179 09/01/2023 3 Citations

Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA) Advances in Radiation Oncology 1 July 2023;8(4) SCOPUS ID: 2-s2.0-85153041702 07/01/2023 3 Citations

Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United States. (Raldow AC, Siker ML, Bonner JA, Chen Y, Liu FF, Metz JM, Movsas B, Potters L, Schultz CJ, Wilson E, Wang X, Romero T, Steinberg ML, Jagsi R) Adv Radiat Oncol 2023;8(5):101210 PMID: 37152892 PMCID: PMC10160693 SCOPUS ID: 2-s2.0-85153065179 05/08/2023 3 Citations

Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA) Adv Radiat Oncol 2023;8(4):101206 PMID: 37152489 PMCID: PMC10157111 SCOPUS ID: 2-s2.0-85153041702 05/08/2023 3 Citations

Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma. (Amidon RF, Santos-Pinheiro F, Straza M, Prah MA, Mueller WM, Krucoff MO, Connelly JM, Kleefisch CJ, Coss DJ, Cochran EJ, Bovi JA, Schultz CJ, Schmainda KM) Front Oncol 2022;12:1066191 PMID: 36561526 PMCID: PMC9763264 SCOPUS ID: 2-s2.0-85144231369 12/24/2022 3 Citations

Development of a multi-layer quality assurance program to evaluate the uncertainty of deformable dose accumulation in adaptive radiotherapy. (Zhong H, Garcia-Alvarez JA, Kainz K, Tai A, Ahunbay E, Erickson B, Schultz CJ, Li XA) Med Phys 2023 Mar;50(3):1766-1778 PMID: 36434751 PMCID: PMC10033340 SCOPUS ID: 2-s2.0-85144053188 11/27/2022 8 Citations

Incorporating uncertainty bounds in daily deformable dose accumulation for adaptive radiation therapy of head-and-neck cancer. (García-Alvarez JA, Zhong H, Schultz CJ, Li XA, Kainz K) Med Phys 2023 Apr;50(4):2474-2487 PMID: 36346034 SCOPUS ID: 2-s2.0-85142299603 11/09/2022 6 Citations

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians. (Hall WA, Paulson E, Li XA, Erickson B, Schultz C, Tree A, Awan M, Low DA, McDonald BA, Salzillo T, Glide-Hurst CK, Kishan AU, Fuller CD) CA Cancer J Clin 2022 Jan;72(1):34-56 PMID: 34792808 PMCID: PMC8985054 SCOPUS ID: 2-s2.0-85119184109 11/19/2021 93 Citations

Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy. (Bero EH, Rein LE, Banerjee A, Straza MW, Lawton CAF, Schultz CJ, Erickson BA, Siker ML, Hall WA) Pract Radiat Oncol 2021;11(6):453-459 PMID: 34742459 SCOPUS ID: 2-s2.0-85118502646 11/08/2021 8 Citations

A closer look at 30 day hospital readmissions after head and neck cancer surgery (Puccia R, Ramamurthi A, Grond SE, McCormick C, Ng A, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz C, Wong S, Shreenivas A, Zenga J) American Journal of Otolaryngology Head and Neck Medicine and Surgery 1 September 2021;42(5) SCOPUS ID: 2-s2.0-85108366965 09/01/2021 2 Citations

Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry. (de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Daamen LA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Philippens MEP, Sahgal A, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Tseng CL, Hall WA, Verkooijen HM, MR-Linac Consortium) Int J Radiat Oncol Biol Phys 2021 Nov 15;111(4):867-875 PMID: 34265394 PMCID: PMC9764331 SCOPUS ID: 2-s2.0-85113219681 07/16/2021 45 Citations

BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort. (Vassilakopoulou M, Won M, Curran WJ, Souhami L, Prados MD, Langer CJ, Rimm DL, Hanna JA, Neumeister VM, Melian E, Diaz AZ, Atkins JN, Komarnicky LT, Schultz CJ, Howard SP, Zhang P, Dicker AP, Knisely JPS) Oncology 2021;99(9):580-588 PMID: 33957633 PMCID: PMC8491475 SCOPUS ID: 2-s2.0-85107468485 05/07/2021 6 Citations

The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer. (Kish JA, Zhang Q, Langer CJ, Nguyen-Tân PF, Rosenthal DI, Weber RS, List MA, Wong SJ, Garden AS, Hu K, Trotti AM, Bonner JA, Jones CU, Yom SS, Thorstad W, Schultz CJ, Ridge JA, Shenouda G, Harris J, Le QT) J Geriatr Oncol 2021 Jul;12(6):937-944 PMID: 33814339 PMCID: PMC8829803 SCOPUS ID: 2-s2.0-85103725742 04/06/2021 8 Citations

Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522. (Awan MJ, Gittleman H, Barnholtz-Sloan J, Machtay M, Nguyen-Tan PF, Rosenthal DI, Schultz C, Huth BJ, Thorstad WL, Frank SJ, Kim H, Foote RL, Lango MN, Shenouda G, Suntharalingam M, Harris J, Zhang Q, Le QT, Yao M, NRG Oncology Group) Oral Oncol 2021 May;116:105241 PMID: 33640577 PMCID: PMC8144062 SCOPUS ID: 2-s2.0-85101423773 03/01/2021 5 Citations

Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813. (Fleming JL, Pugh S, Bell EH, Chang SM, McElroy J, Becker A, Timmers CD, Shih HA, Ashby L, Hunter GK, Bahary JP, Schultz CJ, Kavanagh BD, Yung WA, Robins I, Werner-Wasik M, Chakravarti A) Int J Radiat Oncol Biol Phys 2020 Dec 01;108(5):1399 PMID: 33427658 SCOPUS ID: 2-s2.0-85100069396 01/12/2021 1 Citation

In Reply to Peñagarícano. (Bovi JA, Schultz CJ) Int J Radiat Oncol Biol Phys 2021 Feb 01;109(2):641 PMID: 33422280 SCOPUS ID: 2-s2.0-85098481483 01/11/2021

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy. (de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM) Front Oncol 2020;10:1328 PMID: 33014774 PMCID: PMC7505056 SCOPUS ID: 2-s2.0-85091425211 10/06/2020 109 Citations

Improving Structure Delineation for Radiation Therapy Planning Using Dual-Energy CT. (Noid G, Zhu J, Tai A, Mistry N, Schott D, Prah D, Paulson E, Schultz C, Li XA) Front Oncol 2020;10:1694 PMID: 32984048 PMCID: PMC7484725 SCOPUS ID: 2-s2.0-85090756213 09/29/2020 21 Citations

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy (de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM) Frontiers in Oncology 7 September 2020;10 SCOPUS ID: 2-s2.0-85091425211 09/07/2020 109 Citations

Improving Structure Delineation for Radiation Therapy Planning Using Dual-Energy CT (Noid G, Zhu J, Tai A, Mistry N, Schott D, Prah D, Paulson E, Schultz C, Li XA) Frontiers in Oncology 28 August 2020;10 SCOPUS ID: 2-s2.0-85090756213 08/28/2020 21 Citations

Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac. (Hall WA, Straza MW, Chen X, Mickevicius N, Erickson B, Schultz C, Awan M, Ahunbay E, Li XA, Paulson ES) PLoS One 2020;15(8):e0236570 PMID: 32764748 PMCID: PMC7413561 SCOPUS ID: 2-s2.0-85089301005 08/09/2020 65 Citations

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma. (Bell EH, Zhang P, Shaw EG, Buckner JC, Barger GR, Bullard DE, Mehta MP, Gilbert MR, Brown PD, Stelzer KJ, McElroy JP, Fleming JL, Timmers CD, Becker AP, Salavaggione AL, Liu Z, Aldape K, Brachman DG, Gertler SZ, Murtha AD, Schultz CJ, Johnson D, Laack NN, Hunter GK, Crocker IR, Won M, Chakravarti A) J Clin Oncol 2020 Oct 10;38(29):3407-3417 PMID: 32706640 PMCID: PMC7527157 SCOPUS ID: 2-s2.0-85092564201 07/25/2020 168 Citations

4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience (Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA) Clinical and Translational Radiation Oncology July 2020;23:72-79 SCOPUS ID: 2-s2.0-85084968086 07/01/2020 120 Citations

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes. (Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ) Int J Radiat Oncol Biol Phys 2020 Nov 15;108(4):979-986 PMID: 32599030 PMCID: PMC8655709 SCOPUS ID: 2-s2.0-85089292279 07/01/2020 25 Citations

4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience. (Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA) Clin Transl Radiat Oncol 2020 Jul;23:72-79 PMID: 32490218 PMCID: PMC7256110 SCOPUS ID: 2-s2.0-85084968086 06/04/2020 120 Citations

The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525. (Robins HI, Eickhoff J, Gilbert MR, Armstrong TS, Shi W, De Groot JF, Schultz CJ, Hunter GK, Valeinis E, Roach M 3rd, Youssef EF, Souhami L, Howard SP, Lieberman FS, Herman JG, Zhang P, Mehta MP) Neurooncol Pract 2019 Dec;6(6):473-478 PMID: 31832217 PMCID: PMC6899045 SCOPUS ID: 2-s2.0-85079125614 12/14/2019 10 Citations

The association between BMI and BSA-temozolomideinduced myelosuppression toxicities: A correlative analysis of NRG oncology RTOG 0525 (Robins HI, Eickhoff J, Gilbert MR, Armstrong TS, Shi W, De Groot JF, Schultz CJ, Hunter GK, Valeinis E, Roach M, Youssef EF, Souhami L, Howard SP, Lieberman FS, Herman JG, Zhang P, Mehta MP) Neuro-Oncology Practice 1 December 2019;6(6):473-478 SCOPUS ID: 2-s2.0-85079125614 12/01/2019 10 Citations

Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation (North L, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Shreenivas A, Wong S, Graboyes E, Pipkorn P, Zenga J) American Journal of Otolaryngology Head and Neck Medicine and Surgery November - December 2019;40(6) SCOPUS ID: 2-s2.0-85071985153 11/01/2019 12 Citations

The transformation of radiation oncology using real-time magnetic resonance guidance: A review. (Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, Bassetti MF, Robinson CG, Minsky BD, Choudhury A, Tersteeg RJHA, Schultz CJ, MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium) Eur J Cancer 2019 Nov;122:42-52 PMID: 31614288 PMCID: PMC8447225 SCOPUS ID: 2-s2.0-85073099937 10/16/2019 165 Citations

Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer. (Zenga J, Divi V, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Shreenivas A, Wong S, Jackson RS, Pipkorn P) Oral Oncol 2019 Nov;98:125-131 PMID: 31586894 SCOPUS ID: 2-s2.0-85072773115 10/07/2019 29 Citations

Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation. (North L, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Shreenivas A, Wong S, Graboyes E, Pipkorn P, Zenga J) Am J Otolaryngol 2019;40(6):102282 PMID: 31519432 SCOPUS ID: 2-s2.0-85071985153 09/15/2019 12 Citations

Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer. (Lorenz JW, Schott D, Rein L, Mostafaei F, Noid G, Lawton C, Bedi M, Li XA, Schultz CJ, Paulson E, Hall WA) Cureus 2019 Apr 20;11(4):e4510 PMID: 31259119 PMCID: PMC6590865 07/02/2019

Lymph node yield from neck dissection in HPV-associated oropharyngeal cancer. (Zenga J, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Wong S, Jackson RS, Pipkorn P) Laryngoscope 2020 Mar;130(3):666-671 PMID: 31206708 SCOPUS ID: 2-s2.0-85067854046 06/18/2019 18 Citations

Reassessing the Role of Radiation Therapy for the Treatment of Lymphoma: Historical Perspective and Opportunities in the Era of Image-Guided and Adaptive Radiation Therapy. (Schultz CJ) J Oncol Pract 2019 Apr;15(4):175-176 PMID: 30970226 SCOPUS ID: 2-s2.0-85064721617 04/11/2019 2 Citations

Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study. (Zenga J, Graboyes E, Janz T, Drake V, Rettig E, Desai S, Nickel C, Shabani S, Padhya T, Scarpinato M, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Wong S, Jackson RS, Pipkorn P) Otolaryngol Head Neck Surg 2019 Jul;161(1):74-81 PMID: 30753110 SCOPUS ID: 2-s2.0-85061834834 02/13/2019 23 Citations

Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420. (Lieberman FS, Wang M, Robins HI, Tsien CI, Curran WJ Jr, Werner-Wasik M, Smith RP, Schultz C, Hartford AC, Zhang P, Mehta MP) Int J Radiat Oncol Biol Phys 2019 Mar 15;103(4):878-886 PMID: 30496882 PMCID: PMC7034757 SCOPUS ID: 2-s2.0-85061550338 11/30/2018 11 Citations

Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order. (Bovi JA, Schultz CJ, Mehta MP, Corn BW) Int J Radiat Oncol Biol Phys 2018 Sep 01;102(1):59-60 PMID: 30102204 SCOPUS ID: 2-s2.0-85050800872 08/14/2018 1 Citation

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial. (Bell EH, Zhang P, Fisher BJ, Macdonald DR, McElroy JP, Lesser GJ, Fleming J, Chakraborty AR, Liu Z, Becker AP, Fabian D, Aldape KD, Ashby LS, Werner-Wasik M, Walker EM, Bahary JP, Kwok Y, Yu HM, Laack NN, Schultz CJ, Gray HJ, Robins HI, Mehta MP, Chakravarti A) JAMA Oncol 2018 Oct 01;4(10):1405-1409 PMID: 29955793 PMCID: PMC6117103 SCOPUS ID: 2-s2.0-85054767268 06/30/2018 151 Citations

Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT. (Wu H, Chen X, Yang X, Tao Y, Xia Y, Deng X, Zheng C, Robbins J, Schultz C, Li XA) Int J Radiat Oncol Biol Phys 2018 Nov 15;102(4):1308-1318 PMID: 29891201 SCOPUS ID: 2-s2.0-85048541509 06/13/2018 32 Citations

Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. (Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA) Neurosurgery 2018 May 01;82(5):595-603 PMID: 29669114 SCOPUS ID: 2-s2.0-85068839760 04/19/2018 11 Citations

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. (Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ Jr) J Neurooncol 2018 Mar;137(1):39-47 PMID: 29404979 PMCID: PMC6020014 SCOPUS ID: 2-s2.0-85042457134 02/07/2018 30 Citations

Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. (Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY) Int J Radiat Oncol Biol Phys 2018 Jun 01;101(2):274-284 PMID: 28964588 SCOPUS ID: 2-s2.0-85030158569 10/02/2017 59 Citations

R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology. (Verkooijen HM, Kerkmeijer LGW, Fuller CD, Huddart R, Faivre-Finn C, Verheij M, Mook S, Sahgal A, Hall E, Schultz C) Front Oncol 2017;7:59 PMID: 28421162 PMCID: PMC5378068 SCOPUS ID: 2-s2.0-85018453765 04/20/2017 99 Citations

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. (Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Belanger K, Schultz C, Hunter G, Mehta M) Neuro Oncol 2017 Feb 01;19(2):252-258 PMID: 27994066 PMCID: PMC5463834 SCOPUS ID: 2-s2.0-85019070871 12/21/2016 77 Citations

The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development. (Kerkmeijer LG, Fuller CD, Verkooijen HM, Verheij M, Choudhury A, Harrington KJ, Schultz C, Sahgal A, Frank SJ, Goldwein J, Brown KJ, Minsky BD, van Vulpen M, MR-Linac Consortium Clinical Steering Committee) Front Oncol 2016;6:215 PMID: 27790408 PMCID: PMC5061756 SCOPUS ID: 2-s2.0-84997170377 10/30/2016 107 Citations

Clinical Significance of Updated MRI Simulation Versus Immediate Postoperative MRI for Radiation Treatment Planning in Patients With Glioblastoma: Changes in FLAIR Signal (A. Dayal M.L. Siker S. Firat J.A. Bovi C.J. Schultz W.M. Mueller J.M. Connelly S.D. Rand) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E103, OCTOBER 01, 2016 10/01/2016

Pulsed Reduced Dose Rate Reirradiation (PRDR) Using Modulated Arc (mARC) Intensity Modulated Radiation Therapy for Recurrent Gliomas: Initial Clinical Outcomes of a Novel Technique (M.L. Siker S. Firat D. Prah C.J. Schultz A. Dayal C. Masterson J.M. Connelly W.M. Mueller J.A. Bovi ) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E125-E126, OCTOBER 01, 2016 10/01/2016

Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy in Head and Neck Squamous Cell Carcinoma: A Pooled Analysis of NRG Oncology/RTOG 0129 and 0522 (M. Yao Q. Zhang C.R. Woods P.F. Nguyen-Tan D.I. Rosenthal A.S. Garden W.L. Thorstad P.R. Anne C.J. Schultz J.J. Caudell E. Filion J.A. Ridge C.U. Jones H. Kim S.S. Yom D. Raben J.A. Bonner M. Machtay J. Harris Q.T. Le) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S116-S117, OCTOBER 01, 2016 10/01/2016

A Mutation and Prognostic Biomarker Study in Grade II and III Gliomas Utilizing a Combined Cohort of NRG Oncology/RTOG 9802 and 9813 (E.H. Bell J.P. McElroy J. Fleming C. Timmers A.R. Chakraborty A.L. Salavaggione S.M. Chang E.G. Shaw K. Aldape D. Brachman C.J. Schultz H.A. Shih M. Curtis G.K. Hunter A.D. Murtha P. Zhang M. Won M.P. Mehta A. Chakravarti) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S91, OCTOBER 01, 2016 10/01/2016

Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent chemotherapy and radiation therapy in high-risk squamous cell carcinoma of the head and neck. (b. Spencer SA, Harris J, Wheeler RH, Machtay M, SCHULTZ C, Spanos W, Rotman M, Meredith R, Ang KK ) N Engl J Med 350 (19): 1937-1944 08/08/2016

Treatment of recurrent glioblastoma with Bevacizumba with or without re-irradiation using a pulsed-low-dose radietion therapy technique: A single institution experience. ( Bovi JA, Prah M, Rand SD, SCHULTZ CJ, Schmanda KM) Int J Radiat Oncol Biol Phys 90:S1, Abs #2179, S288 08/08/2016

Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. (b. Spencer SA, Harris J, Wheeler RH, Machtay M, SCHULTZ C, Spanos W, Rotman M, Meredith R, Ang KK) Head Neck Mar;30(3):281-8 08/08/2016

Development of an inverse optimization package to plan non-uniform dose distributions based on spatially inhomogeneous radiosensitivity extracted from biological images (Cheng GP, Ahunbay E, SCHULTZ C, Li XA) Med Phys 34(4)April 08/08/2016

Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma. (Nguyen HS, Milbach N, Hurrell SL, Cochran E, Connelly J, Bovi JA, Schultz CJ, Mueller WM, Rand SD, Schmainda KM, LaViolette PS) AJNR Am J Neuroradiol 2016 Dec;37(12):2201-2208 PMID: 27492073 PMCID: PMC5161572 SCOPUS ID: 2-s2.0-85006469905 08/06/2016 71 Citations

Technical Note: Dose effects of 1.5 T transverse magnetic field on tissue interfaces in MRI-guided radiotherapy. (Chen X, Prior P, Chen GP, Schultz CJ, Li XA) Med Phys 2016 Aug;43(8):4797 PMID: 27487897 SCOPUS ID: 2-s2.0-84979775187 08/05/2016 48 Citations

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. (Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ Jr) N Engl J Med 2016 Apr 07;374(14):1344-55 PMID: 27050206 PMCID: PMC5170873 SCOPUS ID: 2-s2.0-84963804957 04/07/2016 900 Citations

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. (Glass J, Won M, Schultz CJ, Brat D, Bartlett NL, Suh JH, Werner-Wasik M, Fisher BJ, Liepman MK, Augspurger M, Bokstein F, Bovi JA, Solhjem MC, Mehta MP) J Clin Oncol 2016 May 10;34(14):1620-5 PMID: 27022122 PMCID: PMC4872318 SCOPUS ID: 2-s2.0-84969916579 03/30/2016 121 Citations

Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. (Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS) J Neurooncol 2015 May;123(1):179-88 PMID: 25894597 SCOPUS ID: 2-s2.0-84929836750 04/22/2015 24 Citations

Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer. (Feng M, Yang C, Chen X, Xu S, Moraru I, Lang J, Schultz C, Li XA) Int J Radiat Oncol Biol Phys 2015 Apr 01;91(5):1041-7 PMID: 25832695 SCOPUS ID: 2-s2.0-84925305626 04/04/2015 27 Citations

Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting. (Elson A, Walker A, Bovi JA, Schultz C) Front Oncol 2015;5:27 PMID: 25709970 PMCID: PMC4321406 SCOPUS ID: 2-s2.0-84923230933 02/25/2015 6 Citations

Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma. (Elson A, Bovi J, Siker M, Schultz C, Paulson E) J Neurooncol 2015 May;122(3):549-58 PMID: 25700835 SCOPUS ID: 2-s2.0-84939984579 02/24/2015 31 Citations

Comparing the quality of passively-scattered proton and photon tomotherapy plans for brain and head and neck disease sites. (Kainz K, Firat S, Wilson JF, Schultz C, Siker M, Wang A, Olson D, Li XA) Phys Med Biol 2015 Mar 21;60(6):2167-77 PMID: 25683607 SCOPUS ID: 2-s2.0-84924658067 02/17/2015 1 Citation

Comprehensive MRI simulation methodology using a dedicated MRI scanner in radiation oncology for external beam radiation treatment planning. (Paulson ES, Erickson B, Schultz C, Allen Li X) Med Phys 2015 Jan;42(1):28-39 PMID: 25563245 SCOPUS ID: 2-s2.0-84917691321 01/08/2015 136 Citations

Effect of treatment modality on the hypothalamic-pituitary function of patients treated with radiation therapy for pituitary adenomas: hypothalamic dose and endocrine outcomes. (Elson A, Bovi J, Kaur K, Maas D, Sinson G, Schultz C) Front Oncol 2014;4:73 PMID: 24782984 PMCID: PMC3988389 SCOPUS ID: 2-s2.0-84901047928 05/02/2014 18 Citations

Combined online and offline adaptive radiation therapy: a dosimetric feasibility study. (Yang C, Liu F, Ahunbay E, Chang YW, Lawton C, Schultz C, Wang D, Firat S, Erickson B, Li XA) Pract Radiat Oncol 2014;4(1):e75-83 PMID: 24621436 SCOPUS ID: 2-s2.0-84890868988 03/14/2014 12 Citations

Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM). (Krauze AV, Won M, Graves C, Corn BW, Muanza TM, Howard SP, Mahadevan A, Schultz CJ, Haas ML, Mehta MP, Camphausen KA) Biomark Res 2013 Oct 31;1(1):29 PMID: 24252135 PMCID: PMC4177620 SCOPUS ID: 2-s2.0-84938352985 11/21/2013 5 Citations

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. (Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge S, Baumert B, Hopkins KI, Tzuk-Shina T, Brown PD, Chakravarti A, Curran WJ Jr, Mehta MP) J Clin Oncol 2013 Nov 10;31(32):4085-91 PMID: 24101040 PMCID: PMC3816958 SCOPUS ID: 2-s2.0-84891785971 10/09/2013 901 Citations

The role of pre-treatment white matter abnormalities in developing white matter changes following whole brain radiation: a volumetric study. (Sabsevitz DS, Bovi JA, Leo PD, Laviolette PS, Rand SD, Mueller WM, Schultz CJ) J Neurooncol 2013 Sep;114(3):291-7 PMID: 23813291 SCOPUS ID: 2-s2.0-84883157173 07/03/2013 10 Citations

American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS). (Seung SK, Larson DA, Galvin JM, Mehta MP, Potters L, Schultz CJ, Yajnik SV, Hartford AC, Rosenthal SA) Am J Clin Oncol 2013 Jun;36(3):310-5 PMID: 23681017 PMCID: PMC4285440 SCOPUS ID: 2-s2.0-84878838107 05/18/2013 105 Citations

SU‐E‐CAMPUS‐J‐05: Extracting Patient‐Specific Radiobiological Parameters From Tumor Regression for Biologically‐Based Adaptive Radiation Therapy of Head and Neck Cancer (Tai A, Schultz C, li X) Medical Physics June 2013;40(6):379 SCOPUS ID: 2-s2.0-85024777726 01/01/2013

SU‐E‐CAMPUS‐T‐04: Plan Quality of Proton Vs. Photon IMRT for Whole Ventricle Irradiation (Kainz K, Wang W, Firat S, Wilson J, Schultz C, li X) Medical Physics June 2013;40(6):380 SCOPUS ID: 2-s2.0-85024790280 01/01/2013

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. (Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG, Schultz CJ, Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M, Molinaro A, Mischel P, Dicker AP, Bredel M, Mehta M) Int J Radiat Oncol Biol Phys 2013 Apr 01;85(5):1206-11 PMID: 23182702 PMCID: PMC4199329 SCOPUS ID: 2-s2.0-84875239034 11/28/2012 141 Citations

American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT). (Hartford AC, Galvin JM, Beyer DC, Eichler TJ, Ibbott GS, Kavanagh B, Schultz CJ, Rosenthal SA, American College of Radiology, American Society for Radiation Oncology) Am J Clin Oncol 2012 Dec;35(6):612-7 PMID: 23165357 SCOPUS ID: 2-s2.0-84870187312 11/21/2012 83 Citations

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. (Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK) Int J Radiat Oncol Biol Phys 2012 Dec 01;84(5):1198-205 PMID: 22749632 PMCID: PMC3465463 SCOPUS ID: 2-s2.0-84869139611 07/04/2012 479 Citations

Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary? (Bedi M, Firat S, Semenenko VA, Schultz C, Tripp P, Byhardt R, Wang D) Int J Radiat Oncol Biol Phys 2012 May 01;83(1):e87-92 PMID: 22516389 SCOPUS ID: 2-s2.0-84859853667 04/21/2012 12 Citations

Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck. (Kharofa J, Choong N, Wang D, Firat S, Schultz C, Sadasiwan C, Wong S) Int J Radiat Oncol Biol Phys 2012 Jun 01;83(2):690-5 PMID: 22112556 SCOPUS ID: 2-s2.0-84861097469 11/25/2011 40 Citations

Internal margin assessment using cine MRI analysis of deglutition in head and neck cancer radiotherapy. (Paulson ES, Bradley JA, Wang D, Ahunbay EE, Schultz C, Li XA) Med Phys 2011 Apr;38(4):1740-7 PMID: 21626908 SCOPUS ID: 2-s2.0-79953644699 06/02/2011 17 Citations

Prognostic value of H-MLH1 after adjusting for RPA class in GBM patients. (Choucair A, Moughan J, Schultz C, Schulsinger A, Mehta M, Curran W) Front Biosci (Elite Ed) 2011 Jun 01;3(3):1182-91 PMID: 21622124 SCOPUS ID: 2-s2.0-80053586047 05/31/2011 2 Citations

Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trial. (McHaffie DR, Chabot P, Dagnault A, Suh JH, Fortin MA, Chang E, Timmerman R, Souhami L, Grecula J, Nabid A, Schultz C, Werner-Wasik M, Gaspar LE, Brachman D, Mody T, Mehta MP) J Neurooncol 2011 Nov;105(2):301-8 PMID: 21523486 SCOPUS ID: 2-s2.0-82955233755 04/28/2011 19 Citations

Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer. (Zundel MT, Michel MA, Schultz CJ, Maheshwari M, Wong SJ, Campbell BH, Massey BL, Blumin J, Wilson JF, Wang D) Int J Radiat Oncol Biol Phys 2011 Dec 01;81(5):e825-32 PMID: 21300450 SCOPUS ID: 2-s2.0-81855184909 02/09/2011 37 Citations

Dynamic MRI analysis of tumor and organ motion during rest and deglutition and margin assessment for radiotherapy of head-and-neck cancer. (Bradley JA, Paulson ES, Ahunbay E, Schultz C, Li XA, Wang D) Int J Radiat Oncol Biol Phys 2011 Dec 01;81(5):e803-12 PMID: 21300480 SCOPUS ID: 2-s2.0-81855184914 02/09/2011 44 Citations

Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study. (Siker ML, Firat SY, Mueller W, Krouwer H, Schultz CJ) Int J Radiat Oncol Biol Phys 2012 Feb 01;82(2):765-72 PMID: 21236600 SCOPUS ID: 2-s2.0-84855841206 01/18/2011 7 Citations

Current management of primary central nervous system lymphoma. (Schultz CJ, Bovi J) Int J Radiat Oncol Biol Phys 2010 Mar 01;76(3):666-78 PMID: 20159361 SCOPUS ID: 2-s2.0-76049085618 02/18/2010 36 Citations

Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy. (Parker SM, Olteanu H, VanTuinen P, Lawton CA, Schultz CJ, Christians KK, Fenske TS) Int J Hematol 2009 Dec;90(5):616-622 PMID: 19937165 SCOPUS ID: 2-s2.0-73449127535 11/26/2009 11 Citations

An on-line replanning method for head and neck adaptive radiotherapy. (Ahunbay EE, Peng C, Godley A, Schultz C, Li XA) Med Phys 2009 Oct;36(10):4776-90 PMID: 19928108 SCOPUS ID: 2-s2.0-70349653543 11/26/2009 60 Citations

Role of radiation therapy in cutaneous melanoma. (Shuff JH, Siker ML, Daly MD, Schultz CJ) Clin Plast Surg 2010 Jan;37(1):147-60 PMID: 19914465 SCOPUS ID: 2-s2.0-70449432830 11/17/2009 8 Citations

Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024. (Rosenthal DI, Harris J, Forastiere AA, Weber RS, Ridge JA, Myers JN, Garden AS, Kuettel MR, Sidhu K, Schultz CJ, Trotti A, Ang KK) J Clin Oncol 2009 Oct 01;27(28):4727-32 PMID: 19720915 PMCID: PMC2754914 SCOPUS ID: 2-s2.0-70350433284 09/02/2009 35 Citations

SU‐FF‐T‐591: Improvement of IMRT Plan Quality with Non‐Isocentric Beam Arrangement for Head and Neck Cancers (Chen G, Hu B, Qi S, Schultz C, Wang D, Li X) Medical Physics June 2009;36(6):2660 SCOPUS ID: 2-s2.0-85024780026 01/01/2009

American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). (Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbott GS, Kavanagh B, Kent JS, Rosenthal SA, Schultz CJ, Tripuraneni P, Gaspar LE, American Society for Therapeutic Radiology and Oncology, American College of Radiology) Int J Radiat Oncol Biol Phys 2009 Jan 01;73(1):9-14 PMID: 19100920 SCOPUS ID: 2-s2.0-57649107185 12/23/2008 89 Citations

Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131. (Vogelbaum MA, Berkey B, Peereboom D, Macdonald D, Giannini C, Suh JH, Jenkins R, Herman J, Brown P, Blumenthal DT, Biggs C, Schultz C, Mehta M) Neuro Oncol 2009 Apr;11(2):167-75 PMID: 18779504 PMCID: PMC2718988 SCOPUS ID: 2-s2.0-65949101643 09/10/2008 63 Citations

Synergistic effect of 15-lipoxygenase 2 and radiation in killing head-and-neck cancer. (Yang Q, Feng Y, Schultz CJ, Li XA, Wu H, Wang D) Cancer Gene Ther 2008 May;15(5):323-30 PMID: 18292796 SCOPUS ID: 2-s2.0-41949103643 02/23/2008 10 Citations

Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. (Vernon MR, Maheshwari M, Schultz CJ, Michel MA, Wong SJ, Campbell BH, Massey BL, Wilson JF, Wang D) Int J Radiat Oncol Biol Phys 2008 Mar 01;70(3):678-84 PMID: 18262086 SCOPUS ID: 2-s2.0-38849083351 02/12/2008 83 Citations

MO‐E‐AUD C‐05: Can Voxel Based Prescription Dose Be Determined From Multiple Physiological MR Modalities for Brain Tumors? (Ahunbay E, Schultz C, li X) Medical Physics June 2008;35(6):2876-2877 SCOPUS ID: 2-s2.0-85024797896 01/01/2008

TH‐C‐AUD C‐04: An Online Correction Method for Interfractional Variations in Head and Neck Cancer (Ahunbay E, Chen G, Peng C, Schultz C, Li X) Medical Physics June 2008;35(6):2972 SCOPUS ID: 2-s2.0-85024784869 01/01/2008

In reply [9] (Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM) Journal of Clinical Oncology 20 September 2007;25(27):4324-4325 SCOPUS ID: 2-s2.0-35148870861 09/20/2007

Possible fractionated regimens for image-guided intensity-modulated radiation therapy of large arteriovenous malformations. (Qi XS, Schultz CJ, Li XA) Phys Med Biol 2007 Sep 21;52(18):5667-82 PMID: 17804888 SCOPUS ID: 2-s2.0-35848966561 09/07/2007 20 Citations

Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. (Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R, Ang KK) Head Neck 2008 Mar;30(3):281-8 PMID: 17764087 SCOPUS ID: 2-s2.0-41649118634 09/04/2007 312 Citations

Development of an inverse optimization package to plan nonuniform dose distributions based on spatially inhomogeneous radiosensitivity extracted from biological images. (Chen GP, Ahunbay E, Schultz C, Li XA) Med Phys 2007 Apr;34(4):1198-205 PMID: 17500451 SCOPUS ID: 2-s2.0-34147140787 05/16/2007 23 Citations

Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. (Li XA, Qi XS, Pitterle M, Kalakota K, Mueller K, Erickson BA, Wang D, Schultz CJ, Firat SY, Wilson JF) Int J Radiat Oncol Biol Phys 2007 Jun 01;68(2):581-91 PMID: 17331669 SCOPUS ID: 2-s2.0-34247893798 03/03/2007 116 Citations

TU‐FF‐A2‐03: Image‐Guided Helical Tomotherapy to Treat Advanced Cancers of the Scalp: Prospects for Dose Conformity and Clinical Outcome (Kainz K, Wilson JF, Schultz C, Jursinic P, li XA) Medical Physics June 2007;34(6):2576 SCOPUS ID: 2-s2.0-85024788691 01/01/2007

SU‐FF‐T‐54: A Three‐Phase Strategy for a Partial Implementation of Biologically Guided Radiation Therapy (li X, Stewart R, Semenenko V, qi S, Chen G, Ahunbay E, Schultz C) Medical Physics June 2007;34(6):2413 SCOPUS ID: 2-s2.0-85024818270 01/01/2007

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. (Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM) J Clin Oncol 2006 Dec 20;24(36):5711-5 PMID: 17116938 SCOPUS ID: 2-s2.0-34247342137 11/23/2006 537 Citations

Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710. (Colman H, Berkey BA, Maor MH, Groves MD, Schultz CJ, Vermeulen S, Nelson DF, Mehta MP, Yung WK, Radiation Therapy Oncology Group) Int J Radiat Oncol Biol Phys 2006 Nov 01;66(3):818-24 PMID: 16887285 SCOPUS ID: 2-s2.0-33748936494 08/05/2006 51 Citations

A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. (Cardinale R, Won M, Choucair A, Gillin M, Chakravarti A, Schultz C, Souhami L, Chen A, Pham H, Mehta M) Int J Radiat Oncol Biol Phys 2006 Aug 01;65(5):1422-8 PMID: 16750317 SCOPUS ID: 2-s2.0-33748569803 06/06/2006 94 Citations

Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. (Wang D, Schultz CJ, Jursinic PA, Bialkowski M, Zhu XR, Brown WD, Rand SD, Michel MA, Campbell BH, Wong S, Li XA, Wilson JF) Int J Radiat Oncol Biol Phys 2006 May 01;65(1):143-51 PMID: 16618577 SCOPUS ID: 2-s2.0-33645964284 04/19/2006 129 Citations

An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor. (Qi XS, Schultz CJ, Li XA) Int J Radiat Oncol Biol Phys 2006 Apr 01;64(5):1570-80 PMID: 16580506 SCOPUS ID: 2-s2.0-33645339524 04/04/2006 55 Citations

Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. (Robins HI, Won M, Seiferheld WF, Schultz CJ, Choucair AK, Brachman DG, Demas WF, Mehta MP) Neuro Oncol 2006 Jan;8(1):47-52 PMID: 16443947 PMCID: PMC1871929 SCOPUS ID: 2-s2.0-31544471131 01/31/2006 60 Citations

SU‐FF‐J‐122: Systematic Study of Inter‐Fractional Variations for Anatomic Sites From Head to Feet (li X, qi X, Mueller K, Jursinic P, Erickson B, Wang D, Schultz C, Firat S, Wilson J) Medical Physics June 2006;33(6):2048 SCOPUS ID: 2-s2.0-85024795120 01/01/2006

TH‐E‐230A‐05: Development of An Integrated Software Platform for Treatment Documentation and Outcome Analysis for IGRT (Chen G, Schultz C, li X) Medical Physics June 2006;33(6):2295 SCOPUS ID: 2-s2.0-85024801615 01/01/2006

Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma. (Fisher B, Seiferheld W, Schultz C, DeAngelis L, Nelson D, Schold SC, Curran W, Mehta M) J Neurooncol 2005 Sep;74(2):201-5 PMID: 16193393 SCOPUS ID: 2-s2.0-26944455874 09/30/2005 85 Citations

Effect of image uncertainty on the dosimetry of trigeminal neuralgia irradiation. (Jursinic PA, Rickert K, Gennarelli TA, Schultz CJ) Int J Radiat Oncol Biol Phys 2005 Aug 01;62(5):1559-67 PMID: 16029818 SCOPUS ID: 2-s2.0-22144497681 07/21/2005 16 Citations

Planning quality and delivery efficiency of sMLC delivered IMRT treatment of oropharyngeal cancers evaluated by RTOG H-0022 dosimetric criteria. (Zhu XR, Schultz CJ, Gillin MT) J Appl Clin Med Phys 2004;5(4):80-95 PMID: 15738923 PMCID: PMC5723523 SCOPUS ID: 2-s2.0-85024952370 03/02/2005 8 Citations

SU‐FF‐J‐105: Tools for Voxel‐By‐Voxel Correlation of Radiotherapy Dose and MR Signals From Multiple Physiological/functional MRI Modalities (Ahunbay E, Schmainda K, Lund R, Prost R, Ulmer J, Alaly J, Deasy J, Schultz C, li X) Medical Physics June 2005;32(6):1944 SCOPUS ID: 2-s2.0-85024792051 01/01/2005

SU‐FF‐T‐369: An Estimation of Radiobiological Parameters From Clinical Outcomes for Radiation Treatment Planning of Brain Tumor (Qi X, Schultz C, Li X) Medical Physics June 2005;32(6):2035-2036 SCOPUS ID: 2-s2.0-85024790140 01/01/2005

SU‐FF‐T‐382: Planning Non‐Uniform Dose Distributions for Brain Tumor (Li X, Ahunbay E, Qi X, Schultz C) Medical Physics June 2005;32(6):2038-2039 SCOPUS ID: 2-s2.0-85024790969 01/01/2005

Late-onset chemosis in patients with head or neck tumors. (Harris GJ, Woo KI, Schultz CJ, Tayani R, Cancel EM) Ophthalmic Plast Reconstr Surg 2004 Nov;20(6):436-41 PMID: 15599243 SCOPUS ID: 2-s2.0-10044255576 12/16/2004 3 Citations

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. (Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ Jr) Int J Radiat Oncol Biol Phys 2004 Nov 01;60(3):853-60 PMID: 15465203 SCOPUS ID: 2-s2.0-4744345914 10/07/2004 494 Citations

Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. (Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK, Radiation Therapy Oncology Group 9501/Intergroup) N Engl J Med 2004 May 06;350(19):1937-44 PMID: 15128893 SCOPUS ID: 2-s2.0-2342517421 05/07/2004 2890 Citations

Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. (Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr) Int J Radiat Oncol Biol Phys 2004 Mar 15;58(4):1147-52 PMID: 15001257 SCOPUS ID: 2-s2.0-12144286887 03/06/2004 113 Citations

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. (Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF) J Clin Oncol 2003 Jul 01;21(13):2529-36 PMID: 12829672 SCOPUS ID: 2-s2.0-0037676125 06/28/2003 442 Citations

Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. (Chang CC, Kampalath B, Schultz C, Bunyi-Teopengco E, Logan B, Eshoa C, Dincer AP, Perkins SL) Arch Pathol Lab Med 2003 Feb;127(2):208-12 PMID: 12562237 SCOPUS ID: 2-s2.0-0037329971 02/04/2003 75 Citations

A new magnetic resonance head coil and head immobilization device for gamma knife radiosurgery: an analysis of geometric distortion and signal/noise characteristics. (Jursinic P, Prost R, Schultz C) J Neurosurg 2002 Dec;97(5 Suppl):563-8 PMID: 12507097 SCOPUS ID: 2-s2.0-0036895794 01/01/2003 9 Citations

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. (DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ, Radiation Therapy Oncology Group Study 93-10) J Clin Oncol 2002 Dec 15;20(24):4643-8 PMID: 12488408 SCOPUS ID: 2-s2.0-0037115536 12/19/2002 664 Citations

Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. (Mehta MP, Shapiro WR, Glantz MJ, Patchell RA, Weitzner MA, Meyers CA, Schultz CJ, Roa WH, Leibenhaut M, Ford J, Curran W, Phan S, Smith JA, Miller RA, Renschler MF) J Clin Oncol 2002 Aug 15;20(16):3445-53 PMID: 12177105 SCOPUS ID: 2-s2.0-0037102391 08/15/2002 137 Citations

RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. (Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R) Int J Radiat Oncol Biol Phys 2001 Dec 01;51(5):1299-304 PMID: 11728690 SCOPUS ID: 2-s2.0-0035576654 12/01/2001 162 Citations

Radiation Therapy Oncology Group. Research Plan 2002-2006. Image-Guided Radiation Therapy Committee. (Michalski J, Purdy JA, Gaspar L, Souhami L, Ballow M, Bradley J, Chao CK, Crane C, Eisbruch A, Fallowil D, Forster K, Fowler J, Gillin MT, Graham ML, Harms WB, Huq MS, Kline RW, Mackie TR, Mukherji S, Podogorsak EB, Roach M, Ryu J, Sandler H, Schultz CJ, Schell M, Verhey LJ, Vicini F, Winter KA, Radiation Therapy Oncology Group) Int J Radiat Oncol Biol Phys 2001;51(3 Suppl 2):60-5 PMID: 11641018 SCOPUS ID: 2-s2.0-0035231532 10/20/2001 18 Citations

Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06. (Corn BW, Dolinskas C, Scott C, Donahue B, Schultz C, Nelson DF, Fisher B) Int J Radiat Oncol Biol Phys 2000 May 01;47(2):299-303 PMID: 10802352 SCOPUS ID: 2-s2.0-0034193236 05/10/2000 18 Citations

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. (Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr) Int J Radiat Oncol Biol Phys 1999 Dec 01;45(5):1109-15 PMID: 10613302 SCOPUS ID: 2-s2.0-0032785167 12/29/1999 74 Citations

Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. (Boyd TS, Harari PM, Tannehill SP, Voytovich MC, Hartig GK, Ford CN, Foote RL, Campbell BH, Schultz CJ) Head Neck 1998 Mar;20(2):132-7 PMID: 9484944 SCOPUS ID: 2-s2.0-0031908690 03/04/1998 102 Citations

The role of dental prostheses in alveolar ridge squamous carcinomas. (Campbell BH, Mark DH, Soneson EA, Freije JE, Schultz CJ) Arch Otolaryngol Head Neck Surg 1997 Oct;123(10):1112-5 PMID: 9339989 SCOPUS ID: 2-s2.0-0030729058 10/27/1997 8 Citations

Carcinoma of the larynx in patients with gastroesophageal reflux. (Freije JE, Beatty TW, Campbell BH, Woodson BT, Schultz CJ, Toohill RJ) Am J Otolaryngol 1996;17(6):386-90 PMID: 8944297 SCOPUS ID: 2-s2.0-0029825772 11/01/1996 109 Citations

Stage I and II Hodgkin's disease in the pediatric population. Long-term follow-up of patients staged predominantly clinically. (Rock DB, Murray KJ, Schultz CJ, Lauer SJ, Wilson JF) Am J Clin Oncol 1996 Apr;19(2):174-8 PMID: 8610644 SCOPUS ID: 2-s2.0-0029986772 04/01/1996 5 Citations

Demonstration of a brachytherapy boost dose-response relationship in glioblastoma multiforme: headed in the right direction. (Schultz CJ) Int J Radiat Oncol Biol Phys 1996 Apr 01;35(1):187-8 PMID: 8641918 SCOPUS ID: 2-s2.0-0029919933 04/01/1996

A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. (Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Noyes WR, Schultz CJ, Loeffler JS, Mehta MP) Int J Radiat Oncol Biol Phys 1996 Apr 01;35(1):27-35 PMID: 8641923 SCOPUS ID: 2-s2.0-0029871287 04/01/1996 462 Citations

Lymphoepithelioma of the larynx. (Andryk J, Freije JE, Schultz CJ, Campbell BH, Komorowski RA) Am J Otolaryngol 1996;17(1):61-3 PMID: 8801819 SCOPUS ID: 2-s2.0-0030026466 01/01/1996 26 Citations

Risk factors which predict persistent cancer in the abnormal larynx following definitive irradiation. (Schultz CJ, Campbell BH, Freije JE, Brook BJ, McAuliffe TL) Eur J Cancer B Oral Oncol 1995 Sep;31B(5):310-4 PMID: 8704647 SCOPUS ID: 2-s2.0-0029558951 09/01/1995 8 Citations

Iododeoxyuridine radiosensitization of human glioblastoma cells exposed to acute and chronic gamma irradiation: mechanistic implications and clinical relevance. (Schultz CJ, Gaffney DK, Lindstrom MJ, Kinsella TJ) Cancer J Sci Am 1995;1(2):151-61 PMID: 9166468 SCOPUS ID: 2-s2.0-0001068772 07/01/1995 16 Citations

Continuous split course irradiation for stage I and II Hodgkin's disease: 20 year experience at the Medical College of Wisconsin. (Rock DB, Schultz CJ, Murray KJ, Wilson JF, Cox JD) Radiother Oncol 1994 Mar;30(3):222-6 PMID: 8209005 SCOPUS ID: 2-s2.0-0028269941 03/01/1994 6 Citations

Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results. (Jacobs JP, Murray KJ, Schultz CJ, Wilson JF, Goswitz MS, Stevens CW, Cox JD) J Clin Oncol 1993 Feb;11(2):233-8 PMID: 8426199 SCOPUS ID: 2-s2.0-0027512337 02/01/1993 68 Citations

Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation. (Schultz CJ, Geard CR) Int J Radiat Oncol Biol Phys 1990 Dec;19(6):1397-403 PMID: 2262364 SCOPUS ID: 2-s2.0-0025681314 12/01/1990 59 Citations

Chloroquine poisoning in a child. (Kelly JC, Wasserman GS, Bernard WD, Schultz C, Knapp J) Ann Emerg Med 1990 Jan;19(1):47-50 PMID: 2297155 SCOPUS ID: 2-s2.0-0025014660 01/01/1990 34 Citations

Last update: 08/02/2025

© 2026 Clinical & Translational Science Institute
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53223

Publication and ontology data from NCBI | Disclaimer and Copyright

This site is a collaborative effort of the Medical College of Wisconsin and the Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number 2UL1TR001436) at the National Institutes of Health (NIH).

Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty

Christopher J. Schultz MD

Professor

Publications (149)